Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A
A. Jankowska, Hideki Makishima, Ramón V. Tiu, et al.
Blood (2011) Vol. 118, Iss. 14, pp. 3932-3941
Open Access | Times Cited: 317

Showing 1-25 of 317 citing articles:

A decade of exploring the cancer epigenome — biological and translational implications
Stephen B. Baylin, Peter A. Jones
Nature reviews. Cancer (2011) Vol. 11, Iss. 10, pp. 726-734
Open Access | Times Cited: 2668
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe, Heidi M. Ott, Gopinath Ganji, et al.
Nature (2012) Vol. 492, Iss. 7427, pp. 108-112
Closed Access | Times Cited: 1684
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Liran I. Shlush, Sasan Zandi, Amanda Mitchell, et al.
Nature (2014) Vol. 506, Iss. 7488, pp. 328-333
Open Access | Times Cited: 1345
Targeting EZH2 in cancer
Kimberly H. Kim, Charles W.M. Roberts
Nature Medicine (2016) Vol. 22, Iss. 2, pp. 128-134
Open Access | Times Cited: 1272
Lessons from the Cancer Genome
Levi A. Garraway, Eric S. Lander
Cell (2013) Vol. 153, Iss. 1, pp. 17-37
Open Access | Times Cited: 1258
Molecular mechanisms and potential functions of histone demethylases
Susanne M. Kooistra, Kristian Helin
Nature Reviews Molecular Cell Biology (2012) Vol. 13, Iss. 5, pp. 297-311
Closed Access | Times Cited: 815
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Raphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Journal of Clinical Oncology (2013) Vol. 31, Iss. 19, pp. 2428-2436
Open Access | Times Cited: 505
Histone lysine demethylases as targets for anticancer therapy
Jonas W. Højfeldt, Karl Agger, Kristian Helin
Nature Reviews Drug Discovery (2013) Vol. 12, Iss. 12, pp. 917-930
Closed Access | Times Cited: 437
DNMT3A in haematological malignancies
Liubin Yang, Rachel E. Rau, Margaret A. Goodell
Nature reviews. Cancer (2015) Vol. 15, Iss. 3, pp. 152-165
Open Access | Times Cited: 429
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
Hideki Makishima, Valeria Visconte, Hirotoshi Sakaguchi, et al.
Blood (2012) Vol. 119, Iss. 14, pp. 3203-3210
Open Access | Times Cited: 364
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia
Panagiotis Ntziachristos, Aristotelis Tsirigos, G. Grant Welstead, et al.
Nature (2014) Vol. 514, Iss. 7523, pp. 513-517
Open Access | Times Cited: 354
Critical roles of non-histone protein lysine methylation in human tumorigenesis
Ryuji Hamamoto, Vassiliki Saloura, Yusuke Nakamura
Nature reviews. Cancer (2015) Vol. 15, Iss. 2, pp. 110-124
Closed Access | Times Cited: 339
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
Omar Abdel‐Wahab, Jie Gao, Mazhar Adli, et al.
The Journal of Experimental Medicine (2013) Vol. 210, Iss. 12, pp. 2641-2659
Open Access | Times Cited: 309
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
Esperanza Such, Ulrich Germing, Luca Malcovati, et al.
Blood (2013) Vol. 121, Iss. 15, pp. 3005-3015
Open Access | Times Cited: 288
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
Manja Meggendorfer, Andreas Roller, Torsten Haferlach, et al.
Blood (2012) Vol. 120, Iss. 15, pp. 3080-3088
Open Access | Times Cited: 287
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
Véronique Gelsi‐Boyer, Mandy Brecqueville, Raynier Devillier, et al.
Journal of Hematology & Oncology (2012) Vol. 5, Iss. 1
Open Access | Times Cited: 265
The genomic landscape of juvenile myelomonocytic leukemia
Elliot Stieglitz, Amaro Taylor‐Weiner, Tiffany Chang, et al.
Nature Genetics (2015) Vol. 47, Iss. 11, pp. 1326-1333
Open Access | Times Cited: 263
The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases
Éric Solary, Olivier Bernard, Ayalew Tefferi, et al.
Leukemia (2013) Vol. 28, Iss. 3, pp. 485-496
Open Access | Times Cited: 256
Clonal architecture of chronic myelomonocytic leukemias
Raphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Blood (2013) Vol. 121, Iss. 12, pp. 2186-2198
Open Access | Times Cited: 254
A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia
Camille Simon, Jalila Chagraoui, Jana Krošl, et al.
Genes & Development (2012) Vol. 26, Iss. 7, pp. 651-656
Open Access | Times Cited: 254
DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies
Annie Im, Alison R. Sehgal, Martin Carroll, et al.
Leukemia (2014) Vol. 28, Iss. 9, pp. 1774-1783
Open Access | Times Cited: 251
IDH2 R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma
Chao Wang, Timothy W. McKeithan, Qiang Gong, et al.
Blood (2015) Vol. 126, Iss. 15, pp. 1741-1752
Open Access | Times Cited: 216
Polycomb repressive complex 2 is required for MLL-AF9 leukemia
Tobias Neff, Amit Sinha, Michael Kluk, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 13, pp. 5028-5033
Open Access | Times Cited: 213
PRC2 mediated H3K27 methylations in cellular identity and cancer
Eric Conway, Evan Healy, Adrian P. Bracken
Current Opinion in Cell Biology (2015) Vol. 37, pp. 42-48
Closed Access | Times Cited: 208
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
Jane Merlevede, Nathalie Droin, Tingting Qin, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 201
Page 1 - Next Page

Scroll to top